메뉴 건너뛰기




Volumn 16, Issue 3, 2009, Pages 230-234

Statin therapy is associated with decreased mortality in patients with infection

Author keywords

Emergency department; Infection; Sepsis; Statins

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

EID: 62249217244     PISSN: 10696563     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1553-2712.2009.00350.x     Document Type: Article
Times cited : (46)

References (22)
  • 1
    • 0034958947 scopus 로고    scopus 로고
    • Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care
    • Angus D, Linde-Zwirble W, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001; 29:1303-10.
    • (2001) Crit Care Med , vol.29 , pp. 1303-1310
    • Angus, D.1    Linde-Zwirble, W.2    Lidicker, J.3    Clermont, G.4    Carcillo, J.5    Pinsky, M.R.6
  • 2
    • 0035826096 scopus 로고    scopus 로고
    • Efficacy and safety of recombinant human activated protein C for severe sepsis
    • Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001; 344:699-709.
    • (2001) N Engl J Med , vol.344 , pp. 699-709
    • Bernard, G.R.1    Vincent, J.L.2    Laterre, P.F.3
  • 3
    • 0036840629 scopus 로고    scopus 로고
    • Risk and the efficacy of antiinflammatory agents: Retrospective and confirmatory studies of sepsis
    • Eichacker PQ, Parent C, Kalil A, et al. Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis. Am J Respir Crit Care Med. 2002; 166:1197-205.
    • (2002) Am J Respir Crit Care Med , vol.166 , pp. 1197-1205
    • Eichacker, P.Q.1    Parent, C.2    Kalil, A.3
  • 4
    • 25444492831 scopus 로고    scopus 로고
    • Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death
    • Abraham E, Laterre PF, Garg R, et al. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med. 2005; 353:1332-41.
    • (2005) N Engl J Med , vol.353 , pp. 1332-1341
    • Abraham, E.1    Laterre, P.F.2    Garg, R.3
  • 5
    • 20844459638 scopus 로고    scopus 로고
    • Fluvast- atin reduces the 4-year cardiac risk in patients with multivessel disease
    • Lemos PA, de Feyter PJ, Serruys PW, et al. Fluvast- atin reduces the 4-year cardiac risk in patients with multivessel disease. Int J Cardiol. 2005; 98:479-86.
    • (2005) Int J Cardiol , vol.98 , pp. 479-486
    • Lemos, P.A.1    de Feyter, P.J.2    Serruys, P.W.3
  • 6
    • 4143083577 scopus 로고    scopus 로고
    • Prior statin therapy is associated with a decreased rate of severe sepsis
    • Almog Y, Shefer A, Novack V, et al. Prior statin therapy is associated with a decreased rate of severe sepsis. Circulation 2004; 110:880-5.
    • (2004) Circulation , vol.110 , pp. 880-885
    • Almog, Y.1    Shefer, A.2    Novack, V.3
  • 7
    • 0035887840 scopus 로고    scopus 로고
    • The effect of statins on mortality in patients with bacter- emia
    • Liappis AP, Kan VL, Rochester CG, Simon GL. The effect of statins on mortality in patients with bacter- emia. Clin Infect Dis. 2001; 33:1352-7.
    • (2001) Clin Infect Dis , vol.33 , pp. 1352-1357
    • Liappis, A.P.1    Kan, V.L.2    Rochester, C.G.3    Simon, G.L.4
  • 8
    • 29844445926 scopus 로고    scopus 로고
    • Statin therapy is associated with fewer deaths in patients with bacteraemia
    • Kruger P, Fitzsimmons K, Cook D, Jones M, Nimmo G. Statin therapy is associated with fewer deaths in patients with bacteraemia. Intensive Care Med. 2006; 32:75-9.
    • (2006) Intensive Care Med , vol.32 , pp. 75-79
    • Kruger, P.1    Fitzsimmons, K.2    Cook, D.3    Jones, M.4    Nimmo, G.5
  • 9
    • 29844438975 scopus 로고    scopus 로고
    • Statin therapy prior to ICU admission: Protection against infection or a severity marker?
    • Fernandez R, De Pedro VJ, Artigas A. Statin therapy prior to ICU admission: protection against infection or a severity marker? Intensive Care Med. 2006; 32:160-4.
    • (2006) Intensive Care Med , vol.32 , pp. 160-164
    • Fernandez, R.1    De Pedro, V.J.2    Artigas, A.3
  • 10
    • 34249287370 scopus 로고    scopus 로고
    • Statins do not improve short-term survival in an oriental population with sepsis
    • Yang KC, Chien JY, Tseng WK, Hsueh PR, Yu CJ, Wu CC. Statins do not improve short-term survival in an oriental population with sepsis. Am J Emerg Med. 2007; 25:494-501.
    • (2007) Am J Emerg Med , vol.25 , pp. 494-501
    • Yang, K.C.1    Chien, J.Y.2    Tseng, W.K.3    Hsueh, P.R.4    Yu, C.J.5    Wu, C.C.6
  • 11
    • 33750360916 scopus 로고    scopus 로고
    • Simvastatin suppresses endotoxin-induced upregulation of tolllike receptors 4 and 2 in vivo
    • Niessner A, Steiner S, Speidl WS, et al. Simvastatin suppresses endotoxin-induced upregulation of tolllike receptors 4 and 2 in vivo. Atherosclerosis 2006; 189:408-13.
    • (2006) Atherosclerosis , vol.189 , pp. 408-413
    • Niessner, A.1    Steiner, S.2    Speidl, W.S.3
  • 13
    • 33644595198 scopus 로고    scopus 로고
    • Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery
    • Chello M, Patti G, Candura D, et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Crit Care Med. 2006; 34:660-7.
    • (2006) Crit Care Med , vol.34 , pp. 660-667
    • Chello, M.1    Patti, G.2    Candura, D.3
  • 14
    • 2642553075 scopus 로고    scopus 로고
    • HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis
    • Merx MW, Liehn EA, Janssens U, et al. HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis. Circulation 2004; 109:2560-5.
    • (2004) Circulation , vol.109 , pp. 2560-2565
    • Merx, M.W.1    Liehn, E.A.2    Janssens, U.3
  • 15
    • 34447559811 scopus 로고    scopus 로고
    • Performance of severity of illness scoring systems in emergency department patients with infection
    • Howell MD, Donnino MW, Talmor D, Clardy P, Ngo L, Shapiro NI. Performance of severity of illness scoring systems in emergency department patients with infection. Acad Emerg Med. 2007; 14:709-14.
    • (2007) Acad Emerg Med , vol.14 , pp. 709-714
    • Howell, M.D.1    Donnino, M.W.2    Talmor, D.3    Clardy, P.4    Ngo, L.5    Shapiro, N.I.6
  • 16
    • 0037351815 scopus 로고    scopus 로고
    • Mortality in Emergency Department Sepsis (MEDS) score: A prospectively derived and validated clinical prediction rule
    • Shapiro NI, Wolfe RE, Moore RB, Smith E, Burdick E, Bates DW. Mortality in Emergency Department Sepsis (MEDS) score: a prospectively derived and validated clinical prediction rule. Crit Care Med. 2003; 31:670-5.
    • (2003) Crit Care Med , vol.31 , pp. 670-675
    • Shapiro, N.I.1    Wolfe, R.E.2    Moore, R.B.3    Smith, E.4    Burdick, E.5    Bates, D.W.6
  • 17
    • 0023092594 scopus 로고
    • A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
    • Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40:373-83.
    • (1987) J Chronic Dis , vol.40 , pp. 373-383
    • Charlson, M.E.1    Pompei, P.2    Ales, K.L.3    MacKenzie, C.R.4
  • 18
    • 10744233133 scopus 로고    scopus 로고
    • Statins increase thrombomodulin expression and function in human endothelial cells by a nitric oxide-dependent mechanism and counteract tumor necrosis factor alpha- induced thrombomodulin downregulation
    • Shi J, Wang J, Zheng H, et al. Statins increase thrombomodulin expression and function in human endothelial cells by a nitric oxide-dependent mechanism and counteract tumor necrosis factor alpha- induced thrombomodulin downregulation. Blood Coagul Fibrinolysis. 2003; 14:575-85.
    • (2003) Blood Coagul Fibrinolysis , vol.14 , pp. 575-585
    • Shi, J.1    Wang, J.2    Zheng, H.3
  • 19
    • 33846930580 scopus 로고    scopus 로고
    • Effects of simvastatin in abdominal sepsis in rats
    • Souza Neto JL, Araujo Filho I, Rego AC, et al. Effects of simvastatin in abdominal sepsis in rats. Acta Cir Bras. 2006; 21(Suppl 4):8-12.
    • (2006) Acta Cir Bras , vol.21 , Issue.SUPPL. 4 , pp. 8-12
    • Souza Neto, J.L.1    Araujo Filho, I.2    Rego, A.C.3
  • 20
    • 33947305316 scopus 로고    scopus 로고
    • Simvasta- tin increases neutrophil apoptosis and reduces inflammatory reaction after coronary surgery
    • Chello M, Anselmi A, Spadaccio C, et al. Simvasta- tin increases neutrophil apoptosis and reduces inflammatory reaction after coronary surgery. Ann Thorac Surg. 2007; 83:1374-80.
    • (2007) Ann Thorac Surg , vol.83 , pp. 1374-1380
    • Chello, M.1    Anselmi, A.2    Spadaccio, C.3
  • 21
    • 33847729386 scopus 로고    scopus 로고
    • Beneficial effects of statins on the microcirculation during sepsis: The role of nitric oxide
    • McGown CC, Brookes ZL. Beneficial effects of statins on the microcirculation during sepsis: the role of nitric oxide. Br J Anaesth. 2007; 98:163-75.
    • (2007) Br J Anaesth , vol.98 , pp. 163-175
    • McGown, C.C.1    Brookes, Z.L.2
  • 22
    • 9344256068 scopus 로고    scopus 로고
    • Simvastatin prevents vascular hyporeactivity during inflammation
    • Pleiner J, Schaller G, Mittermayer F, et al. Simvastatin prevents vascular hyporeactivity during inflammation. Circulation 2004; 110:3349-54.
    • (2004) Circulation , vol.110 , pp. 3349-3354
    • Pleiner, J.1    Schaller, G.2    Mittermayer, F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.